Development and production of a diagnostic kit for the SARS-CoV-2 virus by RT-PCR
- Funded by International Centre for Genetic Engineering and Biotechnology (ICGEB)
- Total publications:0 publications
Grant number: CRP/DZA20-03
Grant search
Key facts
Disease
COVID-19start year
-99Known Financial Commitments (USD)
$0Funder
International Centre for Genetic Engineering and Biotechnology (ICGEB)Principal Investigator
Mohammed SebaihiaResearch Location
AlgeriaLead Research Institution
University Hassiba BenboualiResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Diagnostics
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
There is little doubt that accurate pathogen detection methods are fundamental to any public health strategies aimed at monitoring and limiting the spread of infectious diseases. This is best illustrated by the current COVID-19 pandemic, caused by the novel coronavirus SARS-CoV-2. The World Health Organization has made it abundantly clear that comprehensive testing is the most effective way to prevent infections and save lives. Of the currently available methods for the detection of SARS-CoV-2, the RT-qPCR is considered to be the gold standard. However, the deployment of RT-qPCR tests has been rather variable internationally due to the high global demand and the interruption of the supply chain; and thus, many developing countries, including Algeria, have experienced severe shortages of these kits, which has limited their testing capabilities. The main objective of this project is to produce locally all the enzymes, primers and probes necessary for cost-effective RTqPCR kits